Accueil
Marchés
Graphique & Idées
Algo
Nouvelles
Store
Courtiers
Télécharger
Calendrier Economique
Signaux de trading
Terminal Web
Heatmap
Tapez
/
pour rechercher : @user, $symbol
Recherche
Se connecter
Créer un compte
Français
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Italiano
Türkçe
NYXH
#3863
Nyxoah SA Ordinary Shares
3.2
3
USD
-1.22%
Secteur:
Soins de Santé
Base:
USD
Devise de Profit:
USD
Range quotidien
Range Annuel
Changement quotidien
-1.22%
Changement Mensuel
+2.87%
Evolution sur 6 mois
-45.99%
Changement Annuel
-44.97%
Clôture Précédente
3.2
7
Open
3.2
3
Bid
Ask
Low
3.2
3
High
3.2
3
Volume
1
Marchés
Actions des Marchés US
Soins de Santé
NYXH
Open full chart
Financials
Overview
Relevé
Statistics
Quarterly
Annual
Value
2021
2022
2023
2024
2025
TTM
Key stats
Total common shares outstanding
25.77 M
25.85 M
28.67 M
37.43 M
43.03 M
134.97 M
Valuation ratios
Enterprise value
592.76 M
136.73 M
135.48 M
299.42 M
197.92 M
769.55 M
Price to earnings ratio
—
—
—
—
—
—
Price to sales ratio
—
—
—
—
—
—
Price to cash flow ratio
—
—
—
—
—
—
Price to book ratio
—
—
—
—
—
—
Enterprise value to EBITDA ratio
—
—
—
—
—
—
Profitability ratios
Return on assets %
—
—
—
—
—
—
Return on equity %
—
—
—
—
—
—
Return on invested capital %
—
—
—
—
—
—
Gross margin %
—
—
—
—
—
—
Operating margin %
—
—
—
—
—
—
EBITDA margin %
—
—
—
—
—
—
Net margin %
—
—
—
—
—
—
Liquidity ratios
Quick ratio
—
—
—
—
—
—
Current ratio
—
—
—
—
—
—
Inventory turnover
—
—
—
—
—
—
Asset turnover
—
—
—
—
—
—
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
Long term debt to total assets ratio
—
—
—
—
—
—
Long term debt to total equity ratio
—
—
—
—
—
—
Per share metrics
Operating cash flow per share
—
—
—
—
—
—
EBIT per share
—
—
—
—
—
—
EBITDA per share
—
—
—
—
—
—
Total debt per share
—
—
—
—
—
—
Cash per share
—
—
—
—
—
—
Net current asset value per share
—
—
—
—
—
—
Tangible book value per share
—
—
—
—
—
—
Working capital per share
—
—
—
—
—
—
Book value per share
—
—
—
—
—
—
Nouvelles
Stifel abaisse l’objectif de cours de Nyxoah à 8$ après révision de la valorisation
Cantor Fitzgerald réitère sa recommandation sur Nyxoah lors du lancement américain
Nyxoah SA (NYXH) Q4 2025 Earnings Call Transcript
Nyxoah SA (NYXH) Reports Q4 Loss, Misses Revenue Estimates
Nyxoah à la conférence Oppenheimer : focus stratégique sur le lancement américain
Nyxoah at Oppenheimer Conference: Strategic U.S. Launch Focus
KORU Medical Systems, Inc. (KRMD) Reports Q4 Loss, Beats Revenue Estimates
Veeva Systems (VEEV) Q4 Earnings and Revenues Surpass Estimates
Nyxoah SA (NYXH) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
Stifel maintient sa recommandation d’achat sur l’action Nyxoah avec un objectif de 12$
Stifel reiterates Buy rating on Nyxoah stock, maintains $12 price target
Nyxoah Gains Favorable CMS Reimbursement Ruling for Genio System